Schwartz, G. G., Gabriel Steg, P., Bhatt, D. L., Bittner, V. A., Diaz, R., Goodman, S. G., . . . Szarek, M. (2021). Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score–Matched Analysis of the ODYSSEY OUTCOMES Trial. Circulation.
Chicago-стиль цитированияSchwartz, Gregory G., et al. "Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score–Matched Analysis of the ODYSSEY OUTCOMES Trial." Circulation 2021.
MLA-цитированиеSchwartz, Gregory G., et al. "Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score–Matched Analysis of the ODYSSEY OUTCOMES Trial." Circulation 2021.